当前位置：
X-MOL 学术
›
J. Am. Acad. Dermatol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Efficacy and safety of stapokibart (CM310) in adults with moderate-to-severe atopic dermatitis: A multicenter, randomized, double-blind, placebo-controlled phase 3 trial
Journal of the American Academy of Dermatology ( IF 12.8 ) Pub Date : 2024-07-20 , DOI: 10.1016/j.jaad.2024.07.1447 Yan Zhao 1 , Litao Zhang 2 , Jianzhong Zhang 1 ,
中文翻译：
Stapokibart (CM310) 对中重度特应性皮炎成人的疗效和安全性：一项多中心、随机、双盲、安慰剂对照 3 期试验
更新日期：2024-07-20
Journal of the American Academy of Dermatology ( IF 12.8 ) Pub Date : 2024-07-20 , DOI: 10.1016/j.jaad.2024.07.1447 Yan Zhao 1 , Litao Zhang 2 , Jianzhong Zhang 1 ,
Affiliation
中文翻译：
Stapokibart (CM310) 对中重度特应性皮炎成人的疗效和安全性：一项多中心、随机、双盲、安慰剂对照 3 期试验
京公网安备 11010802027423号